VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 69 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $60,000 | -17.8% | 10,165 | -62.5% | 0.01% | -16.7% |
| Q4 2021 | $73,000 | +2.8% | 27,100 | 0.0% | 0.01% | +20.0% |
| Q3 2021 | $71,000 | -53.3% | 27,100 | -26.4% | 0.01% | -50.0% |
| Q2 2021 | $152,000 | -63.8% | 36,800 | -58.7% | 0.01% | -66.7% |
| Q1 2021 | $420,000 | +6.1% | 89,158 | +61.2% | 0.03% | +11.1% |
| Q4 2020 | $396,000 | -17.3% | 55,317 | +23.3% | 0.03% | -15.6% |
| Q3 2020 | $479,000 | +7.9% | 44,852 | +27.5% | 0.03% | +6.7% |
| Q2 2020 | $444,000 | +214.9% | 35,166 | +248.9% | 0.03% | +233.3% |
| Q4 2019 | $141,000 | -27.3% | 10,078 | -1.9% | 0.01% | +12.5% |
| Q3 2018 | $194,000 | -91.7% | 10,276 | -91.4% | 0.01% | -91.0% |
| Q2 2018 | $2,335,000 | -16.4% | 119,500 | -19.6% | 0.09% | -5.3% |
| Q1 2018 | $2,792,000 | -3.6% | 148,600 | -14.8% | 0.09% | +11.9% |
| Q4 2017 | $2,895,000 | +122.2% | 174,400 | +175.6% | 0.08% | +95.3% |
| Q3 2017 | $1,303,000 | – | 63,287 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,185,291 | $24,558,594 | 29.60% |
| EcoR1 Capital, LLC | 3,851,507 | $29,695,119 | 0.96% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $27,170,040 | 0.39% |
| EAM Investors, LLC | 123,818 | $954,637 | 0.19% |
| HARBOURVEST PARTNERS LLC | 61,776 | $476,293 | 0.16% |
| Diametric Capital, LP | 12,527 | $96,583 | 0.05% |
| Campbell & CO Investment Adviser LLC | 30,563 | $235,641 | 0.04% |
| CAXTON ASSOCIATES LP | 36,564 | $281,908 | 0.04% |
| FIDUCIARY TRUST CO | 252,303 | $1,945,256 | 0.04% |
| FARALLON CAPITAL MANAGEMENT LLC | 797,000 | $6,144,870 | 0.03% |